Abstract 2149: Copper-67 based targeted radioligand therapy to the somatostatin receptor 2 (SSTR2) provides added efficacy and may prime small cell lung cancer for immunotherapy
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Jaclyn L. Lange, Lachlan E. Mclnnes, Kurt R. Gehlsen, Jessica Van Zuylekom, Benjamin Blyth, Stacey E. Rudd, Paul S. Donnelly, Matthew Harris
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409632258